Cargando…
CD44 expressed by myeloid cells promotes glioma invasion
Glioblastoma multiforme (GBM) is one of the most common and malignant brain tumors in adulthood with a median survival of only 15 months. This poor prognosis is related to GBM’s ability to extensively infiltrate the surrounding brain parenchyma resulting in diffuse spread of neoplastic cells in the...
Autores principales: | Ivanova, Ekaterina L., Costa, Barbara, Eisemann, Tanja, Lohr, Sabrina, Boskovic, Pavle, Eichwald, Viktoria, Meckler, Jasmin, Jugold, Manfred, Orian-Rousseau, Veronique, Peterziel, Heike, Angel, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386454/ https://www.ncbi.nlm.nih.gov/pubmed/35992852 http://dx.doi.org/10.3389/fonc.2022.969787 |
Ejemplares similares
-
Podoplanin Positive Myeloid Cells Promote Glioma Development by Immune Suppression
por: Eisemann, Tanja, et al.
Publicado: (2019) -
A Set of Cell Lines Derived from a Genetic Murine Glioblastoma Model Recapitulates Molecular and Morphological Characteristics of Human Tumors
por: Costa, Barbara, et al.
Publicado: (2021) -
An advanced glioma cell invasion assay based on organotypic brain slice cultures
por: Eisemann, Tanja, et al.
Publicado: (2018) -
CD44 Acts as a Signaling Platform Controlling Tumor Progression and Metastasis
por: Orian-Rousseau, Véronique
Publicado: (2015) -
CD44 regulates Wnt signaling at the level of LRP6
por: Orian-Rousseau, Véronique, et al.
Publicado: (2015)